Sarepta 治療公司
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership780,730 shares
Ownership 1.20%
Point72 Asset Management, L.P. ownership in SRPT / Sarepta Therapeutics, Inc.

2018-02-14 - Point72 Asset Management, L.P. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 780,730 shares of Sarepta Therapeutics, Inc. (MX:SRPT). This represents 1.2 percent ownership of the company. In their previous filing dated 2017-02-23 , Point72 Asset Management, L.P. had reported owning 2,825,103 shares, indicating a decrease of -72.36 percent.

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 31,000 of underlying shares valued at $674,560 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2018-02-14 2018-02-14 13G/A 2,825,103 780,730 -72.36 1.20 -76.92
2017-02-23 2017-02-23 13G 1,904,092 2,825,103 48.37 5.20 48.57
2017-02-14 2017-02-14 13G/A 2,760,794 1,904,092 -31.03 3.50 -42.62
2016-02-16 2016-02-16 13G/A 2,193,600 2,760,794 25.86 6.10 15.09
2015-05-01 2015-05-01 13G 2,193,600 5.30
2015-02-17 2015-02-17 13G/A 1,826,500 4.40
2014-04-30 2014-04-30 13G 2,083,100 5.20

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -207,513 -100.00 0 -100.00
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 207,513 207,513 4,466 0.0050
2025-02-14 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -36,855 -100.00 0 -100.00
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 36,855 -12,058 -24.65 4,603 -40.45 0.0117
2024-09-16 2024-06-30 13F/A-2 SAREPTA THERAPEUTICS COM 803607100 48,913 48,913 7,728 0.0202
2024-08-19 2024-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 48,913 48,913 7,728 0.0202
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 48,913 48,913 7,728 0.0202
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -307,343 -100.00 0 -100.00
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 307,343 -22,026 -6.69 37,256 -1.23 0.1087
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 329,369 280,913 579.73 37,719 464.82 0.1122
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 48,456 -655,299 -93.11 6,679 -92.68 0.0207
2023-05-15 2022-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 703,755 -148,145 -17.39 91,193 -3.16 0.3100
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 703,755 -148,145 91,193 0.3100
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 851,900 426,393 100.21 94,169 195.24 0.3761
2022-08-15 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 425,507 -1,021,704 -70.60 31,896 -71.79 0.1346
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,447,211 296,002 25.71 113,056 9.06 0.4489
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,151,209 -694,791 -37.64 103,666 -39.28 0.4140
2021-11-15 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,846,000 1,427,400 340.99 170,718 424.61 0.7498
2021-08-16 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 418,600 279,614 201.18 32,542 214.14 0.1462
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 138,986 138,986 10,359 0.0484
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -344,710 -100.00 0 -100.00
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 344,710 -351,975 -50.52 44,481 -15.23 0.2339
2019-11-15 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 696,685 696,685 52,474 0.3223
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -260,790 -100.00 0 -100.00
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 260,790 182,897 234.81 31,084 265.69 0.1411
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 77,893 12,123 18.43 8,500 -19.98 0.0415
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 65,770 -199,991 -75.25 10,623 -69.76 0.0438
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 265,761 265,761 35,128 0.1402
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -579,757 -100.00 0 -100.00
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 579,757 -1,065,518 -64.76 32,258 -56.78 0.1392
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,645,275 -380,131 -18.77 74,630 9.31 0.3331
2017-08-14 2017-06-30 13F SAREPTA THERAPEUTICS COM 803607100 2,025,406 1,222,106 152.14 68,276 187.14 0.3830
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM 803607100 803,300 -564,299 -41.26 23,778 -36.61 0.1325
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,367,599 -1,916,688 -58.36 37,513 -81.40 0.2623
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM 803607100 3,284,287 536,687 19.53 201,688 284.92 1.4181
2016-08-15 2016-06-30 13F SAREPTA THERAPEUTICS COM 803607100 2,747,600 -214,631 -7.25 52,397 -9.38 0.3565
2016-05-16 2016-03-31 13F SAREPTA THERAPEUTICS COM 803607100 2,962,231 586,531 24.69 57,823 -36.91 0.4436
2016-02-16 2015-12-31 13F SAREPTA THERAPEUTICS COM 803607100 2,375,700 1,465,330 160.96 91,655 213.54 0.7560
2015-11-16 2015-09-30 13F SAREPTA THERAPEUTICS COM 803607100 910,370 -26,230 -2.80 29,232 2.56 0.2295
2015-08-14 2015-06-30 13F SAREPTA THERAPEUTICS COM 803607100 936,600 -765,600 -44.98 28,501 26.08 0.1974
2015-05-15 2015-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,702,200 150,900 9.73 22,605 0.70 0.1541
2015-02-17 2014-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,551,300 1,324,000 582.49 22,447 368.04 0.1575
2014-11-14 2014-09-30 13F SAREPTA THERAPEUTICS COM 803607100 227,300 -44,800 -16.46 4,796 -40.83 0.0361
2014-08-14 2014-06-30 13F SAREPTA THERAPEUTICS COM 803607100 272,100 272,100 8,106 0.0520
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F SAREPTA THERAPEUTICS COM Call 31,000 675 n/a n/a n/a
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM Call 145,000 190.00 2,794 226.78 n/a n/a n/a
2025-08-14 2025-06-30 13F SAREPTA THERAPEUTICS COM Call 50,000 66.67 855 -55.33 n/a n/a n/a
2025-07-21 2025-03-31 13F/A SAREPTA THERAPEUTICS COM Call 30,000 1,915 n/a n/a n/a
2025-05-15 2025-03-31 13F SAREPTA THERAPEUTICS COM Call 30,000 1,915 n/a n/a n/a
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM Call 33,000 4,000 n/a n/a n/a
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS COM Call 16,500 1,486 n/a n/a n/a
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM Call 200,000 23,838 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM Call 100,000 -50.00 7,409 -33.42 n/a n/a n/a
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM Call 200,000 11,128 n/a n/a n/a
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS COM Call 100,000 -60.00 2,743 -82.13 n/a n/a n/a
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM Call 250,000 0.00 15,353 222.00 n/a n/a n/a
2016-08-15 2016-06-30 13F SAREPTA THERAPEUTICS CALL Call 250,000 4,768 n/a n/a n/a
2016-05-16 2016-03-31 13F SAREPTA THERAPEUTICS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F SAREPTA THERAPEUTICS CALL Call 380,200 14,668 n/a n/a n/a
2015-11-16 2015-09-30 13F SAREPTA THERAPEUTICS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F SAREPTA THERAPEUTICS CALL Call 174,900 0.00 5,322 129.10 n/a n/a n/a
2015-05-15 2015-03-31 13F SAREPTA THERAPEUTICS CALL Call 174,900 -36.45 2,323 -41.66 n/a n/a n/a
2015-02-17 2014-12-31 13F SAREPTA THERAPEUTICS CALL Call 275,200 -60.19 3,982 -72.70 n/a n/a n/a
2014-11-14 2014-09-30 13F SAREPTA THERAPEUTICS CALL Call 691,200 14,584 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM Put 238,900 173.03 4,604 207.69 n/a n/a n/a
2025-08-14 2025-06-30 13F SAREPTA THERAPEUTICS COM Put 87,500 191.67 1,496 -21.84 n/a n/a n/a
2025-07-21 2025-03-31 13F/A SAREPTA THERAPEUTICS COM Put 30,000 1,915 n/a n/a n/a
2025-05-15 2025-03-31 13F SAREPTA THERAPEUTICS COM Put 30,000 1,915 n/a n/a n/a
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM Put 20,000 -33.33 2,424 -29.43 n/a n/a n/a
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM Put 30,000 3,436 n/a n/a n/a
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM Put 25,000 -50.00 3,305 -10.80 n/a n/a n/a
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM Put 50,000 3,705 n/a n/a n/a
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-15 2016-06-30 13F SAREPTA THERAPEUTICS PUT Put 900,000 17,163 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.